Following the same VEGF-D induction protocol, we previously demonstrated the Adipo-VD mice are protected from obesity's metabolic syndrome, with improved glucose handling and reduced liver lipid deposition (Chakraborty et al., 2019). Here, VEGFD is linked to obesity disorder.